ADCYAP1R1 and cancer: On the contrary, peptide agonist PACAP27/38 is downregulated in cancer, which may be indicative for lack of its specificity as GPR55 ligand (PACAP27/38 activates also PAC1 receptor) or signaling bias at GPR55.